Inside the Regulatory Battle Shaping Compounded GLP-1 Access | Scott Brunner

In this episode of Everything GLP-1, Dr. Tom Lavin speaks with Scott Brunner, CEO and President of the Alliance for Pharmacy Compounding, to examine how pharmacy compounding has shaped patient access during the GLP-1 shortage era. Rather than framing compounding as a workaround, Brunner explains how it operates within a rigorous, multilayered regulatory system involving the FDA, USP standards, and state boards of pharmacy.

Together, they discuss how drug makers have sometimes conflated legitimate compounding with counterfeit activity, the growing black market for unapproved peptides, and why personalized, prescriber-directed formulations remain essential for patients whose needs fall outside commercially available options. Brunner also outlines the case for creating a regulated pathway for peptide compounding, including enhanced safety data collection.

Listeners will come away with a clearer understanding of how compounding regulation actually works, why it matters for patient safety and access, and what policy changes may be coming. It is a valuable listen for clinicians, healthcare leaders, and anyone following the future of GLP-1 access and obesity medicine.

DISCLAIMER: Dr. Lavin's podcast is for informational and entertainment purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional for any medical concerns or before making decisions about your health.

Hosted on Acast. See acast.com/privacy for more information.

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(11)

Why Sourcing and Testing Matter in Compounded Peptides | Trey (Joseph) Pierre

In this episode of Everything GLP-1, Dr. Tom Lavin speaks with Trey (Joseph) Pierre, who heads Galleria Medical Pharmacy in New Orleans and ranks among the top compounding pharmacists in the Gulf Sout...

5 Elo 22min

Everything You Need to Know About Compounded GLP-1s in 2026 | Karla Palmer

Compounded GLP-1 medications have become one of the most talked-about topics in healthcare, but there’s also a tremendous amount of confusion surrounding their legality, safety, and role in patient ca...

8 Heinä 44min

Preventing Metabolic Syndrome with GLP-1s | Samantha Spansel

"Everything GLP-1" is a podcast to discuss just that. GLP-1s are everywhere, but there's no one, great place to get quality, professional opinions that can help inform your health journey. Join Dr. To...

10 Kesä 32min

How Weight Loss Treatments Evolved | Ramsey Hare

This episode features Ramsey Hare, Regulatory Compliance Specialist with Lavin National, a former bariatric patient and current GLP-1 patient, for a discussion with Dr. Tom about the evolution of weig...

28 Touko 33min

GLP-1s Are Changing Patient Care | Gibb Clark (part 2)

""Everything GLP-1" is a podcast to discuss just that. GLP-1s are everywhere, but there's no one, great place to get quality, professional opinions that can help inform your health journey. Join Dr. T...

12 Touko 43min